0001209191-16-141805.txt : 20160916 0001209191-16-141805.hdr.sgml : 20160916 20160916164609 ACCESSION NUMBER: 0001209191-16-141805 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160914 FILED AS OF DATE: 20160916 DATE AS OF CHANGE: 20160916 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC CENTRAL INDEX KEY: 0001158895 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-221-2266 MAIL ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Roberts David B CENTRAL INDEX KEY: 0001365731 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-33092 FILM NUMBER: 161889857 MAIL ADDRESS: STREET 1: 55 BRADFORD STREET CITY: NEEDHAM STATE: MA ZIP: 02492 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2016-09-14 2016-09-16 0 0001158895 LEMAITRE VASCULAR INC LMAT 0001365731 Roberts David B C/O LEMAITRE VASCULAR, INC. 63 SECOND AVENUE BURLINGTON MA 01803 1 1 0 0 President and Director Common Stock 2016-09-14 4 S 0 30000 20.3333 D 79793 D Common Stock 2016-09-15 4 S 0 3548 21.0235 D 76245 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $20.18 to $20.55. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $21.00 to $21.14. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. This Form 4/A is filed solely to specify that the Reporting Person's sales were effected pursuant to a Rule 10b5-1 trading plan. Laurie A. Churchill, Attorney-in-fact 2016-09-16